National Kidney Foundation
Overview
The National Kidney Foundation is a non-profit health organization that operates the NKF Innovation Fund, an impact investment initiative that invests in early to mid-stage companies developing innovative therapies and technologies for kidney disease.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Estuary Biotherapeutics | Oct 2026 | Series A | Co-investor |
| Biohope | May 2026 | VC Round | Co-investor |
| Revalia Bio | Sep 2025 | Seed | Co-investor |
| Relavo | May 2024 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Kidney Foundation based?
National Kidney Foundation is headquartered in New York City, New York, United States.
When was National Kidney Foundation founded?
National Kidney Foundation was founded in 1950.
How many portfolio companies does National Kidney Foundation have?
National Kidney Foundation has 4 portfolio companies in Caplight's dataset.
What are some companies in National Kidney Foundation's portfolio?
Recent investments visible on Caplight include Estuary Biotherapeutics, Biohope, Revalia Bio, Revalia Bio, Relavo.
What was National Kidney Foundation's most recent investment?
National Kidney Foundation's most recent investment on Caplight was in Estuary Biotherapeutics in 2026.
What sectors does National Kidney Foundation focus on?
National Kidney Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does National Kidney Foundation focus on?
National Kidney Foundation typically invests at the Early stage.